Fortaz



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 39.5%
Acute Myeloid Leukaemia 11.6%
Pseudomonas Infection 11.6%
Pneumonia 9.3%
Peritonitis 4.7%
Brain Abscess 2.3%
Cystic Fibrosis 2.3%
Diarrhoea 2.3%
Evidence Based Treatment 2.3%
Infection Prophylaxis 2.3%
Osteoporosis 2.3%
Product Used For Unknown Indication 2.3%
Prophylaxis 2.3%
Skin Infection 2.3%
Staphylococcal Infection 2.3%
Rash 14.8%
Drug Ineffective 7.4%
Medication Error 7.4%
Pancreatitis Acute 7.4%
Pruritus 7.4%
Confusional State 3.7%
Dehydration 3.7%
Hallucination 3.7%
Hepatic Enzyme Increased 3.7%
Infusion Site Irritation 3.7%
Ischaemia 3.7%
Meningitis Aseptic 3.7%
Muscle Contractions Involuntary 3.7%
Myoclonus 3.7%
Neurological Symptom 3.7%
Neutropenia 3.7%
Oral Discomfort 3.7%
Pharmaceutical Product Complaint 3.7%
Post Procedural Complication 3.7%
Product Packaging Quantity Issue 3.7%
Secondary
Chronic Myeloid Leukaemia 25.0%
Peritoneal Dialysis 25.0%
Peritonitis 25.0%
Sepsis 25.0%
Rash Macular 33.3%
Drug Hypersensitivity 16.7%
Peritonitis Bacterial 16.7%
Respiratory Failure 16.7%
Syncope 16.7%
Concomitant
Drug Use For Unknown Indication 34.3%
Product Used For Unknown Indication 10.9%
Pain 8.5%
Multiple Myeloma 5.5%
Nausea 5.0%
Sedation 4.9%
Acute Lymphocytic Leukaemia 4.5%
Prophylaxis 4.2%
Dry Skin 2.8%
Anti-infective Therapy 2.3%
Osteoporosis 2.2%
Anaemia 2.1%
Premedication 1.9%
Thrombosis Prophylaxis 1.7%
Depression 1.6%
Diuretic Therapy 1.6%
Hypertension 1.6%
Agitation 1.5%
Antiplatelet Therapy 1.5%
Acute Myeloid Leukaemia 1.4%
Wound Secretion 17.6%
Wound Infection Pseudomonas 9.5%
Injury 6.8%
Sepsis 6.8%
Weight Decreased 6.8%
Oedema Peripheral 5.4%
Vomiting 5.4%
Hypernatraemia 4.1%
Peritonitis Bacterial 4.1%
Renal Failure 4.1%
Transverse Sinus Thrombosis 4.1%
White Blood Cell Count Decreased 4.1%
Deep Vein Thrombosis 2.7%
Foot Fracture 2.7%
Haematochezia 2.7%
Hyperglycaemia 2.7%
Leukocytosis 2.7%
Pneumonitis 2.7%
Pyrexia 2.7%
Renal Failure Chronic 2.7%